Vol. 4, Issue 1-2, 2022May 23, 2022 BST
The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström’s Macroglobulinemia
The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström’s Macroglobulinemia
Obada Ababneh, Hassan Abushukair, Aref Qarqash, Sebawe Syaj, Samer Al Hadidi,
Ababneh, Obada, Hassan Abushukair, Aref Qarqash, Sebawe Syaj, and Samer Al Hadidi. 2022. “The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström’s Macroglobulinemia.” Clinical Hematology International 4 (1–2): 21–29. https://doi.org/10.1007/s44228-022-00007-5.